“EIC Accelerator 190195672 – Laser bioprinting device and in vivo applications
The use of laser bioprinting in biotech and regenerative medicine can help resolve clinical conditions that are either currently untreatable and result in loss of life or serious deterioration of quality of life. PhosPrint created an innovative dual beam laser bioprinting device and process which comprises novel surgical protocols for on-site laser bioprinting of autologous urothelial cells. The approach is employed to create a neobladder in cancer patients after the removal of their affected organ. PhosPrint’s brand-new approach overcomes the gold standard of cystoplasty that causes severe side effects since it uses unsafe intestinal epithelium to recreate the bladder”.